A randomized controlled trial comparing capecitabine 5-days-on/2-days-off regimen with conventional regimen in stage II and III colorectal cancer.
- Conditions
- StageII(high risk) and stageIII resectable colorectal cancer
- Registration Number
- JPRN-UMIN000032865
- Lead Sponsor
- Wakayama Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 110
Not provided
1. duplicated active cancer 2. history of severe drug hypersensitivity 3. clinically problematic infection 4. it is judged that registration in this study is difficult due to clinically problematic mental / neurological diseases 5. any of the following complications i) diabetes with poor control ii) hypertension with poor control iii) interstitial pneumonia or pulmonary fibrosis iv) intestinal palsy or intestinal obstruction v) clinically problematic heart disease 6. already undergoing other chemotherapy before and after surgery 7. temporary ileostomy/colostomy closure is scheduled and the administration period of continuous 24 weeks is interrupted for a long time (8) Other cases that the doctor in charge judged unsuitable for safely carrying out this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method feasibility
- Secondary Outcome Measures
Name Time Method